Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BJCT-BIOJECT-needle less injection product -- Ignore unavailable to you. Want to Upgrade?

To: Michael C. Woodward who wrote (59)	10/26/1997 7:26:00 PM
From: J. Stone	Read Replies (2) \| Respond to of 534

BJCT @ $3 sounds dreamy to me...<g> I agree that there is currently alot of churning on this stock. Fact is, three months ago it was at about half a buck, so alot of people are probably taking profits, day-trading; etc. Once we are able to get past these factors, however, BJCT should be able to start moving on up. (Personally, I see no reason why it won't, seeing as how positive the last announcement was...). It's been a long time coming! regards, JS